Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Affluent Medical SA ( (FR:AFME) ) has issued an announcement.
Affluent Medical has appointed Liane Teplitsky, a seasoned executive in the medical device industry, to its Board of Directors. Her extensive experience in healthcare and technology sectors, particularly in leading market development and sales for medical devices, is expected to significantly contribute to the company’s advancement in clinical development and commercialization of its innovative medical devices for treating mitral valve regurgitation.
More about Affluent Medical SA
Affluent Medical is a French medical technologies company founded by Truffle Capital, aiming to become a global leader in treating structural heart diseases and urinary incontinence. The company focuses on developing minimally invasive, innovative, adjustable, and biomimetic implants designed to restore essential physiological functions, with candidate products currently undergoing clinical studies.
YTD Price Performance: 0.40%
Average Trading Volume: 1,166
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €53.09M
For an in-depth examination of AFME stock, go to TipRanks’ Stock Analysis page.